Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
DAJ McDougall, J Martin, EG Playford… - … of pharmacokinetics and …, 2016 - Springer
Abstract Model based personalised dosing (MBPD) is a sophisticated form of individualised
therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to …
therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to …
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
A David, J Mcdougall, J Martin… - Journal of …, 2016 - search.proquest.com
Abstract Model based personalised dosing (MBPD) is a sophisticated form of individualised
therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to …
therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to …
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
DAJ McDougall, J Martin… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Model based personalised dosing (MBPD) is a sophisticated form of individualised therapy,
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.
DA McDougall, J Martin, EG Playford… - … of Pharmacokinetics and …, 2015 - europepmc.org
Model based personalised dosing (MBPD) is a sophisticated form of individualised therapy,
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
DAJ McDougall, J Martin, EG Playford… - … of Pharmacokinetics and …, 2016 - infona.pl
Model based personalised dosing (MBPD) is a sophisticated form of individualised therapy,
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
[引用][C] Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
DAJ McDougall, J Martin… - Journal of …, 2015 - espace.library.uq.edu.au
Model based personalised dosing (MBPD) is a sophisticated form of individualised therapy,
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to estimate …
[引用][C] Determination of a suitable voriconazole pharmacokinetic model for personalised dosing
DAJ McDougall, J Martin, EG Playford… - … of Pharmacokinetics and …, 2015 - cir.nii.ac.jp
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.
D McDougall, J Martin, EG Playford… - … of Pharmacokinetics & …, 2016 - search.ebscohost.com
Abstract Model based personalised dosing (MBPD) is a sophisticated form of individualised
therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to …
therapy, where a population pharmacokinetic (PK) or pharmacodynamic model is utilised to …